AU7622798A - Application of thalidomide to the treatment of Parkinson's disease and Parkisonian syndromes - Google Patents

Application of thalidomide to the treatment of Parkinson's disease and Parkisonian syndromes

Info

Publication number
AU7622798A
AU7622798A AU76227/98A AU7622798A AU7622798A AU 7622798 A AU7622798 A AU 7622798A AU 76227/98 A AU76227/98 A AU 76227/98A AU 7622798 A AU7622798 A AU 7622798A AU 7622798 A AU7622798 A AU 7622798A
Authority
AU
Australia
Prior art keywords
parkisonian
thalidomide
syndromes
parkinson
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76227/98A
Inventor
Given Not
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Publication of AU7622798A publication Critical patent/AU7622798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU76227/98A 1996-12-05 1997-12-02 Application of thalidomide to the treatment of Parkinson's disease and Parkisonian syndromes Abandoned AU7622798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR96/14936 1996-12-05
FR9614936A FR2756737B1 (en) 1996-12-05 1996-12-05 APPLICATION OF THALIDOMIDE TO THE TREATMENT OF PARKINSON'S DISEASE AND PARKINSONIAN SYNDROMES
PCT/FR1997/002175 WO1998024433A1 (en) 1996-12-05 1997-12-02 Application of thalidomide to the treatment of parkinson's disease and parkisonian syndromes

Publications (1)

Publication Number Publication Date
AU7622798A true AU7622798A (en) 1998-06-29

Family

ID=9498364

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76227/98A Abandoned AU7622798A (en) 1996-12-05 1997-12-02 Application of thalidomide to the treatment of Parkinson's disease and Parkisonian syndromes

Country Status (5)

Country Link
EP (1) EP0939636A1 (en)
JP (1) JP2001505215A (en)
AU (1) AU7622798A (en)
FR (1) FR2756737B1 (en)
WO (1) WO1998024433A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2833850B1 (en) 2001-12-26 2004-01-23 Look Fixations Sa DEVICE FOR MOUNTING A FIXING ELEMENT USED ON A SLIDING BOARD
FR2834904B1 (en) 2002-01-21 2004-02-20 Look Fixations Sa SLIDING BOARD AND REMOVABLE PIECE FORMING A COVER FOR MOUNTING ON SUCH A BOARD
US20050143344A1 (en) * 2003-12-30 2005-06-30 Zeldis Jerome B. Methods and compositions using immunomodulatory compounds for the treatment and management of central nervous system disorders or diseases
US20050182097A1 (en) * 2003-12-30 2005-08-18 Zeldis Jerome B. Methods and compositions using thalidomide for the treatment and management of central nervous system disorders or diseases
JP5339588B2 (en) * 2008-11-10 2013-11-13 国立大学法人 新潟大学 A therapeutic drug for schizophrenia containing thalidomide or its derivatives as an active ingredient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0712310A1 (en) * 1993-08-04 1996-05-22 Andrulis Pharmaceuticals Corporation Use of tumor necrosis factor inhibitors together with antiviral agents and therapeutic compositions thereof against hiv infection
US5434170A (en) * 1993-12-23 1995-07-18 Andrulis Pharmaceuticals Corp. Method for treating neurocognitive disorders

Also Published As

Publication number Publication date
JP2001505215A (en) 2001-04-17
EP0939636A1 (en) 1999-09-08
WO1998024433A1 (en) 1998-06-11
FR2756737B1 (en) 1999-01-08
FR2756737A1 (en) 1998-06-12

Similar Documents

Publication Publication Date Title
GR980300033T1 (en) Compositions for the treatment of dermatological disorders and methods for their use
AU7623096A (en) Use of epinastine in the treatment of pain
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
ZA963935B (en) The use of glyceryl triacetate for treatment of onychomycoses
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU2387097A (en) Substituted benzylamines and their use for the treatment of depression
HK1026096A1 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
HUP0003244A2 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases and pharmaceutical compositions thereof
AU7622798A (en) Application of thalidomide to the treatment of Parkinson's disease and Parkisonian syndromes
AU6281298A (en) Use of lofexidine in the treatment of behavioral disorders
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU5446798A (en) Compositions and methods for the treatment of gastrointestinal disorders
AU2154695A (en) Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
IL133398A0 (en) (s) 2-methylamino-2-phenyl - n-butyl 3,4,5 - trimethoxybenzoate and its application to the treatment of chronic pain
AUPN115095A0 (en) Analysis of and compositions and methods for the treatment of disease
AU8049098A (en) Composition and methods for the treatment of inflammatory diseases
AU1931895A (en) Treatment of graft-versus-host disease
EP0880318A4 (en) Therapeutic composition from sugar cane and therapeutic uses thereof
AU1002697A (en) Topical compositions for the treatment of skin disease
GB9616504D0 (en) Therapeutic product and its use
AU7699496A (en) Use of 2-iminobenzothiazolines for treating parkinson's disease and parkinsonian syndromes
ZA951440B (en) Novel opiold peptides for the treatment of pain and use thereof
AU5397994A (en) Treatment of skin disorders